[Drug use and driving]
- PMID: 25956300
- DOI: 10.1016/j.lpm.2015.03.007
[Drug use and driving]
Abstract
Some drugs are known to impair driving because they can change the vision or hearing, and/or disrupt the intellectual or motor abilities: impaired vigilance, sedation, disinhibition effect, the coordination of movement disorders and the balance. The doctor during prescribing and the pharmacist during deliverance of drug treatment should inform their patients of the potential risks of drugs on driving or operating machinery. The driver has direct responsibility, who hired him and him alone, to follow the medical advice received. The pictograms on the outer packaging of medicinal products intended to classify substances according to their risk driving: The driver can whether to observe simple precautions (level one "be prudent"), or follow the advice of a health professional (level two "be very careful"), or if it is totally not drive (level three "danger caution: do not drive"). This classification only evaluates the intrinsic danger of drugs but not the individual variability. Medicines should be taken into account also the conditions for which the medication is prescribed. It is important to inform the patient on several points.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.
Similar articles
-
[Medicine and driving: Alcohol and other toxins].Presse Med. 2015 Oct;44(10):1048-54. doi: 10.1016/j.lpm.2015.04.001. Presse Med. 2015. PMID: 26453285 Review. French.
-
[Drugs and driving].J Pharm Belg. 2013 Jun;(2):4-11. J Pharm Belg. 2013. PMID: 23798181 Review. French.
-
[Drugs and street traffic. Playing it safe for yourself and your patient].MMW Fortschr Med. 2003 Jun 5;145(23):28-32. MMW Fortschr Med. 2003. PMID: 12854221 German.
-
Civil responsibility for driving under the influence of pharmaceutical drugs in Germany.Med Law. 1995;14(1-2):23-35. Med Law. 1995. PMID: 7666744
-
[Establishing a System for Effectively Explaining Indications for Driving Prohibition Contained in Drug Package Inserts].Yakugaku Zasshi. 2017;137(3):337-340. doi: 10.1248/yakushi.16-00237-5. Yakugaku Zasshi. 2017. PMID: 28250330 Japanese.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical